Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 2019

View Archived Issues

Amgen's monoclonal antibody targeting ASGPR 1 well tolerated in phase I study

Workaround may be mutation agnostic treatment for cystic fibrosis

Equillium initiates phase I/II study of EQ-001

Japanese researchers present phase I data for GEN-0101 in CRPC

ZV-0508 as a promising new ADC candidate for the treatment of 5T4-positive cancers

Plasma protein profiling identifies new protein biomarkers associated with NAFLD

New method greenlights Myc targeting

TPH1 inhibitors patented by Gwangju Institute of Science and Technology and collaborators

Overcoming resistance in KRAS-mutant tumors

Merck & Co. discovers proteasome subunit beta type-8 inhibitors

Helmholtz-Zentrum fuer Infektionsforschung presents E. coli DNA gyrase inhibitors

The University of Rochester identifies new angiogenesis inhibitors

Gilead identifies new indoleamine 2,3-dioxygenase 1 inhibitors

Praluent approved in Europe to reduce CV risk in adults with established atherosclerotic CV disease

Stroke candidate pyragrel safe and well tolerated in phase I study

PK/PD evaluation of a single dose of nilotinib in Parkinson's disease patients

First-in-human data presented for KL-1333

New phase I study evaluates CyPep-1 for HPV-induced warts

Aerie begins phase II study of AR-1105 for macular edema due to RVO

New phase II trial assesses TLC-590 for postsurgical pain management following bunionectomy

ReNeuron advances phase I/II retinitis pigmentosa trial of hRPC cell therapy candidate

Allergy Therapeutics' phase III trial of adjuvanted birch allergoid product misses primary endpoint

Phase IIb study of lebrikizumab in moderate to severe atopic dermatitis meets primary endpoint

resTORbio announces plans for phase III program with RTB-101 for respiratory tract infections

European Commission approves MabThera for pemphigus vulgaris

Lexicon initiates phase IIa study of telotristat ethyl in biliary tract cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 14, 2025.
Circode applies circRNA to heart disease drug R&D, in vivo CAR T
BioWorld
Shanghai Circode Biomed Co. Ltd. is set to begin clinical trials of HM-2002, a circular RNA (circRNA)-based drug for ischemic heart disease, having gained IND...
BD’s biosciences & diagnostics unit in $17.5B merger with Waters
BioWorld MedTech
Three months earlier than an expected update on a deal, Becton, Dickinson and Co. reported its biosciences and diagnostic solutions business will combine with...
Ultragenyx hit again, this time with a CRL in rare disease
BioWorld
Manufacturing issues are the latest problem for Ultragenyx Pharmaceutical Inc. to solve after last week’s disappointment in a phase III study to treat brittle...